{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:23:18Z","timestamp":1788441798739,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["EX112-11239SI"],"award-info":[{"award-number":["EX112-11239SI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3N1481"],"award-info":[{"award-number":["CMRPG3N1481"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04838-x","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T01:59:29Z","timestamp":1747792769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic outcomes of symptomatic peripheral artery disease patients with end-stage renal disease undergoing lower limb endovascular treatment: a propensity score-matched analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Shang-Yu","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Ying","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hsiao","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"4838_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395:709\u201333.","journal-title":"Lancet"},{"key":"4838_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000514550","volume":"52","author":"JS Thurlow","year":"2021","unstructured":"Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52:98\u2013107.","journal-title":"Am J Nephrol"},{"key":"4838_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijcard.2018.03.108","volume":"262","author":"HO Kim","year":"2018","unstructured":"Kim HO, Kim J-M, Woo JS, Choi D, Ko Y-G, Ahn C-M, et al. Effects of chronic kidney disease on clinical outcomes in patients with peripheral artery disease undergoing endovascular treatment: analysis from the K-VIS ELLA registry. Int J Cardiol. 2018;262:32\u20137.","journal-title":"Int J Cardiol"},{"key":"4838_CR4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","volume":"110","author":"E Selvin","year":"2004","unstructured":"Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the united States: results from the National health and nutrition examination survey, 1999\u20132000. Circulation. 2004;110:738\u201343.","journal-title":"Circulation"},{"key":"4838_CR5","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.105.607390","volume":"114","author":"S Rajagopalan","year":"2006","unstructured":"Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW, Satayathum S, Lameire N, et al. Peripheral arterial disease in patients with end-stage renal disease. Circulation. 2006;114:1914\u201322.","journal-title":"Circulation"},{"key":"4838_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/ph15050596","volume":"15","author":"SY Tsai","year":"2022","unstructured":"Tsai SY, Li YS, Lee CH, Cha SW, Wang YC, Su TW, et al. Mono or dual antiplatelet therapy for treating patients with peripheral artery disease after lower extremity revascularization: A systematic review and meta-analysis. Pharmaceuticals (Basel). 2022;15:596.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4838_CR7","doi-asserted-by":"crossref","unstructured":"Anantha-Narayanan M, Sheikh AB, Nagpal S, Jelani QU, Smolderen KG, Regan C et al. Systematic review and meta-analysis of outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease. J Vasc Surg. 2021;73:331\u2013\u200940.e4.","DOI":"10.1016\/j.jvs.2020.08.032"},{"key":"4838_CR8","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","volume":"387","author":"A Farber","year":"2022","unstructured":"Farber A, Menard MT, Conte MS, Kaufman JA, Powell RJ, Choudhry NK, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387:2305\u201316.","journal-title":"N Engl J Med"},{"key":"4838_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/1358863X18824654","volume":"24","author":"NV Arinze","year":"2019","unstructured":"Arinze NV, Gregory A, Francis JM, Farber A, Chitalia VC. Unique aspects of peripheral artery disease in patients with chronic kidney disease. Vasc Med. 2019;24:251\u201360.","journal-title":"Vasc Med"},{"key":"4838_CR10","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(23)00462-2","volume":"401","author":"AW Bradbury","year":"2023","unstructured":"Bradbury AW, Moakes CA, Popplewell M, Meecham L, Bate GR, Kelly L, et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023;401:1798\u2013809.","journal-title":"Lancet"},{"key":"4838_CR11","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.jfma.2021.12.020","volume":"121","author":"C-C Lee","year":"2022","unstructured":"Lee C-C, Hsu C-C, Lin M-H, Chen K-H, Wu IW. Hospitalization in patients with dialysis in Taiwan: A nationwide population-based observational study. J Formos Med Assoc. 2022;121:S39\u201346.","journal-title":"J Formos Med Assoc"},{"key":"4838_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/1129729818807336","volume":"20","author":"CF Chen","year":"2019","unstructured":"Chen CF, Chen FA, Lee TL, Liao LF, Chen CY, Tan AC, et al. Current status of dialysis and vascular access in Taiwan. J Vasc Access. 2019;20:368\u201373.","journal-title":"J Vasc Access"},{"issue":"3 Suppl 1","key":"4838_CR13","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","volume":"73","author":"R Saran","year":"2019","unstructured":"Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, et al. US renal data system 2018 annual data report: epidemiology of kidney disease in the united States. Am J Kidney Dis. 2019;73(3 Suppl 1):A7\u20138.","journal-title":"Am J Kidney Dis"},{"key":"4838_CR14","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1186\/1471-2458-13-1107","volume":"13","author":"NT Chang","year":"2013","unstructured":"Chang NT, Chan CL, Lu YT, Hsu JC, Hsu YN, Chu D, et al. Invasively-treated incidence of lower extremity peripheral arterial disease and associated factors in Taiwan: 2000\u20132011 nationwide hospitalized data analysis. BMC Public Health. 2013;13:1107.","journal-title":"BMC Public Health"},{"issue":"6","key":"4838_CR15","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jfma.2019.10.011","volume":"119","author":"HL Huang","year":"2020","unstructured":"Huang HL, Tzeng IS, Chou HH, Hsieh CA, Jang SJ, Ko YL, Chao YC. Contemporary cardiovascular outcomes in Taiwanese patients undergoing endovascular therapy for symptomatic lower extremity peripheral arterial disease. J Formos Med Assoc. 2020;119(6):1052\u201360.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"4838_CR16","first-page":"97","volume":"39","author":"JK Lee","year":"2023","unstructured":"Lee JK, Hsieh IC, Su CH, Huang HL, Lei MH, Chiu KM, Huang CL, et al. Referral, diagnosis, and Pharmacological management of peripheral artery disease: perspectives from Taiwan. Acta Cardiol Sin. 2023;39(1):97\u2013108.","journal-title":"Acta Cardiol Sin"},{"key":"4838_CR17","first-page":"e686","volume":"135","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: A report of the American college of cardiology\/american heart association task force on clinical practice guidelines. Circulation. 2017;135:e686\u2013725.","journal-title":"Circulation"},{"issue":"2","key":"4838_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejvs.2020.11.017","volume":"61","author":"D Lowry","year":"2021","unstructured":"Lowry D, Vitalis A, Al Shakarchi J, Psarros V, Karkhanis S, Saeed M, et al. An extension of the Bollinger scoring system to analyse the distribution of macrovascular disease of the lower limb in diabetes. Eur J Vasc Endovasc Surg. 2021;61(2):280\u201386.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"Suppl S","key":"4838_CR19","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5\u201367.","journal-title":"J Vasc Surg"},{"key":"4838_CR20","unstructured":"Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58. S1-109.e33."},{"key":"4838_CR21","doi-asserted-by":"publisher","first-page":"e005273","DOI":"10.1161\/CIRCOUTCOMES.118.005273","volume":"12","author":"JH Lin","year":"2019","unstructured":"Lin JH, Brunson A, Romano PS, Mell MW, Humphries MD. Endovascular-first treatment is associated with improved amputation-free survival in patients with critical limb ischemia. Circ-Cardiovasc Qual. 2019;12:e005273.","journal-title":"Circ-Cardiovasc Qual"},{"key":"4838_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/1526602815602074","volume":"22","author":"MG Davies","year":"2015","unstructured":"Davies MG, El-Sayed HF. Outcomes of isolated tibial endovascular interventions for tissue loss in CLI patients on Hemodialysis. J Endovasc Ther. 2015;22:681\u20139.","journal-title":"J Endovasc Ther"},{"key":"4838_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.atherosclerosis.2019.12.016","volume":"297","author":"NR Smilowitz","year":"2020","unstructured":"Smilowitz NR, Bhandari N, Berger JS. Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease. Atherosclerosis. 2020;297:149\u201356.","journal-title":"Atherosclerosis"},{"key":"4838_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.ackd.2014.07.005","volume":"21","author":"PS Garimella","year":"2014","unstructured":"Garimella PS, Hirsch AT. Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes. Adv Chronic Kidney Dis. 2014;21:460\u201371.","journal-title":"Adv Chronic Kidney Dis"},{"key":"4838_CR25","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.jvs.2011.01.062","volume":"53","author":"T Willenberg","year":"2011","unstructured":"Willenberg T, Baumann F, Eisenberger U, Baumgartner I, Do D-D, Diehm N. Impact of renal insufficiency on clinical outcomes in patients with critical limb ischemia undergoing endovascular revascularization. J Vasc Surg. 2011;53:1589\u201397.","journal-title":"J Vasc Surg"},{"key":"4838_CR26","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","volume":"69","author":"MS Conte","year":"2019","unstructured":"Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69:3S. -125S.e40.","journal-title":"J Vasc Surg"},{"key":"4838_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ejvs.2014.05.019","volume":"48","author":"S Yamamoto","year":"2014","unstructured":"Yamamoto S, Hosaka A, Okamoto H, Shigematsu K, Miyata T, Watanabe T. Efficacy of revascularization for critical limb ischemia in patients with end-stage renal disease. Eur J Vasc Endovasc Surg. 2014;48:316\u201324.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"4838_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ccd.25676","volume":"86","author":"M Nakano","year":"2015","unstructured":"Nakano M, Hirano K, Yamauchi Y, Iida O, Soga Y, Kawasaki D, et al. Three-year clinical outcome after infrapopliteal angioplasty for critical limb ischemia in Hemodialysis patients with minor or major tissue loss. Catheter Cardiovasc Interv. 2015;86:289\u201398.","journal-title":"Catheter Cardiovasc Interv"},{"key":"4838_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/joic.12393","volume":"30","author":"S Kataoka","year":"2017","unstructured":"Kataoka S, Yamaguchi J, Nakao M, Jujo K, Hagiwara N. Clinical outcome and its predictors in Hemodialysis patients {grigorian, 2019 #1}critical limb ischemia undergoing endovascular therapy. J Interv Cardiol. 2017;30:374\u201381.","journal-title":"J Interv Cardiol"},{"key":"4838_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.avsg.2023.04.020","volume":"94","author":"TW Cheng","year":"2023","unstructured":"Cheng TW, Farber A, Kalish JA, King EG, Rybin D, Siracuse JJ. The effect of chronic and end-stage renal disease on long-term outcomes after infrainguinal bypass. Ann Vasc Surg. 2023;94:129\u201335.","journal-title":"Ann Vasc Surg"},{"key":"4838_CR31","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.jcin.2019.08.006","volume":"12","author":"S Cho","year":"2019","unstructured":"Cho S, Lee YJ, Ko YG, Kang TS, Lim SH, Hong SJ, et al. Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease. JACC Cardiovasc Interv. 2019;12:2359\u201370.","journal-title":"JACC Cardiovasc Interv"},{"key":"4838_CR32","first-page":"2101","volume":"10","author":"PS Garimella","year":"2017","unstructured":"Garimella PS, Balakrishnan P, Correa A, Poojary P, Annapureddy N, Chauhan K, et al. Nationwide trends in hospital outcomes and utilization after lower limb revascularization in patients on Hemodialysis. JACC: Cardiovasc Interv. 2017;10:2101\u201310.","journal-title":"JACC: Cardiovasc Interv"},{"key":"4838_CR33","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jvs.2017.12.048","volume":"68","author":"A Meyer","year":"2018","unstructured":"Meyer A, Fiessler C, Stavroulakis K, Torsello G, Bisdas T, Lang W. Outcomes of dialysis patients with critical limb ischemia after revascularization compared with patients with normal renal function. J Vasc Surg. 2018;68:822\u2013e91.","journal-title":"J Vasc Surg"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04838-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04838-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04838-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T14:05:28Z","timestamp":1747836328000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04838-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4838"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04838-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the ethical guidelines of the 1975 Declaration of Helsinki. It was reviewed and approved by the Institutional Review Board of Chang Gung Medical Foundation (Institutional Review Board of Chang Gung Medical Foundation, IRB No: 202201849B0), which waived the need for an informed consent statement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}